Meseclazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C11H10ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51KFT71THG, chemically known as 7-chloro-3,3a-dihydro-2-methyl-2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one but generally known as meseclazone, which bears US NIH Compound Identifier 34445. European Medicines Agency schedules Meseclazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08783MIG. The term MESECLAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). MESECLAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meseclazone under HS 29349990 and SITC 51579. As of Q4 2014, MESECLAZONE remains the US FDA Preferred Term for this commodity. Meseclazone bears US NLM identifiers UMLS ID C0066015 and NCI Concept Code C73088. SMILES: CC1CC2N(O1)C(=O)C3=C(O2)C=CC(=C3)CL.